Alterity Therapeutics (ASX:ATH) is set to raise AU$40 million via a two-tranche placement at AU$0.011 apiece, according to a Monday Australian bourse filing.
The first tranche of the placement is to raise about AU$12.8 million by issuing 1.2 billion shares and the second tranche is expected to raise about AU$27.2 million by issuing 2.5 billion shares.
Participants will also receive one free attached option per three shares subscribed exercisable at AU$0.028 expiring Feb. 26, 2027.
The proceeds will be used to fund ongoing clinical development programs for its Parkinson's disease drug candidate and general working capital, added the filing.
MST Financial Services was the lead manager for the placement.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。